Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Benefit of Using an Autologous Platelet-rich Fibrin Matrix (Obsidian ASG®) for Treatment of Anastomosis During Rectal Surgery - a Single-blind, Randomized, Multicenter Pilot Study

NCT05174910 is registered in ClinicalTrials.gov with Vivostat as lead sponsor.

NCT NCT05174910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05174910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Benefit of Using an Autologous Platelet-rich Fibrin Matrix (Obsidian ASG®) for Treatment of Anastomosis During Rectal Surgery - a Single-blind, Randomized, Multicenter Pilot Study
Lead sponsor
Vivostat
Phase
Not applicable
Overall status
Unknown status
Start date
December 23, 2021
Completion date
December 31, 2024
Enrollment
250 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

anastomotic leak rectum